Acorah Software Products - Accounts Production 19.2.450 false true 31 August 2024 1 September 2023 false 1 September 2024 31 August 2025 31 August 2025 12837728 Mr Ahmed Ahmed iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12837728 2024-08-31 12837728 2025-08-31 12837728 2024-09-01 2025-08-31 12837728 frs-core:CurrentFinancialInstruments 2025-08-31 12837728 frs-core:ComputerEquipment 2025-08-31 12837728 frs-core:ComputerEquipment 2024-09-01 2025-08-31 12837728 frs-core:ComputerEquipment 2024-08-31 12837728 frs-core:FurnitureFittings 2025-08-31 12837728 frs-core:FurnitureFittings 2024-09-01 2025-08-31 12837728 frs-core:FurnitureFittings 2024-08-31 12837728 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2025-08-31 12837728 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-09-01 2025-08-31 12837728 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-08-31 12837728 frs-core:ShareCapital 2025-08-31 12837728 frs-core:RetainedEarningsAccumulatedLosses 2025-08-31 12837728 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12837728 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 12837728 frs-bus:SmallEntities 2024-09-01 2025-08-31 12837728 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 12837728 frs-bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12837728 frs-bus:OrdinaryShareClass2 2024-09-01 2025-08-31 12837728 frs-bus:OrdinaryShareClass2 2025-08-31 12837728 frs-bus:OrdinaryShareClass3 2024-09-01 2025-08-31 12837728 frs-bus:OrdinaryShareClass3 2025-08-31 12837728 frs-bus:OrdinaryShareClass4 2024-09-01 2025-08-31 12837728 frs-bus:OrdinaryShareClass4 2025-08-31 12837728 frs-core:CostValuation 2024-08-31 12837728 frs-core:AdditionsToInvestments 2025-08-31 12837728 frs-core:CostValuation 2025-08-31 12837728 frs-core:ProvisionsForImpairmentInvestments 2024-08-31 12837728 frs-core:ProvisionsForImpairmentInvestments 2025-08-31 12837728 frs-bus:Director1 2024-09-01 2025-08-31 12837728 frs-bus:Director1 2024-08-31 12837728 frs-bus:Director1 2025-08-31 12837728 frs-countries:EnglandWales 2024-09-01 2025-08-31 12837728 2023-08-31 12837728 2024-08-31 12837728 2023-09-01 2024-08-31 12837728 frs-core:CurrentFinancialInstruments 2024-08-31 12837728 frs-core:ShareCapital 2024-08-31 12837728 frs-core:RetainedEarningsAccumulatedLosses 2024-08-31 12837728 frs-bus:OrdinaryShareClass2 2023-09-01 2024-08-31 12837728 frs-bus:OrdinaryShareClass3 2023-09-01 2024-08-31 12837728 frs-bus:OrdinaryShareClass4 2023-09-01 2024-08-31
Registered number: 12837728
Vivo Medica Ltd
Unaudited Financial Statements
For The Year Ended 31 August 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 12837728
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 189,350 16,789
Investments 5 212,609 109,722
401,959 126,511
CURRENT ASSETS
Debtors 6 202,784 47,434
Cash at bank and in hand 70,579 119,180
273,363 166,614
Creditors: Amounts Falling Due Within One Year 7 (112,833 ) (31,137 )
NET CURRENT ASSETS (LIABILITIES) 160,530 135,477
TOTAL ASSETS LESS CURRENT LIABILITIES 562,489 261,988
PROVISIONS FOR LIABILITIES
Deferred Taxation (3,857 ) (435 )
NET ASSETS 558,632 261,553
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 558,532 261,453
SHAREHOLDERS' FUNDS 558,632 261,553
Page 1
Page 2
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Ahmed Ahmed
Director
28th May 2026
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Vivo Medica Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12837728 . The registered office is 82 Wandsworth Bridge Road, London, SW6 2TF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured from the rendering of services.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Leasehold 10% straight line
Fixtures & Fittings 25% straight line
Computer Equipment 25% straight line
2.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
2.6. Investments
Investments comprise long term loans and are stated at cost less provision for accumulated impairment losses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 2)
3 2
4. Tangible Assets
Land & Property
Leasehold Fixtures & Fittings Computer Equipment Total
£ £ £ £
Cost
As at 1 September 2024 15,050 - 4,476 19,526
Additions 158,871 12,030 2,793 173,694
As at 31 August 2025 173,921 12,030 7,269 193,220
Depreciation
As at 1 September 2024 - - 2,737 2,737
Provided during the period - - 1,133 1,133
As at 31 August 2025 - - 3,870 3,870
Net Book Value
As at 31 August 2025 173,921 12,030 3,399 189,350
As at 1 September 2024 15,050 - 1,739 16,789
5. Investments
Other
£
Cost or Valuation
As at 1 September 2024 109,722
Additions 102,887
As at 31 August 2025 212,609
Provision
As at 1 September 2024 -
As at 31 August 2025 -
Net Book Value
As at 31 August 2025 212,609
As at 1 September 2024 109,722
Page 4
Page 5
6. Debtors
2025 2024
£ £
Due within one year
Trade debtors 46,020 -
Prepayments and accrued income 8,600 11,112
Director's loan account 148,164 36,322
202,784 47,434
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 3,862 -
Corporation tax 96,827 28,112
Other taxes and social security 10,237 2,462
Accruals and deferred income 1,907 563
112,833 31,137
8. Share Capital
2025 2024
Allotted, called up and fully paid £ £
75 Ordinary A shares of £ 1.000 each 75 75
20 Ordinary B shares of £ 1.000 each 20 20
5 Ordinary C shares of £ 1.000 each 5 5
100 100
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 September 2024 Amounts advanced Amounts repaid Amounts written off As at 31 August 2025
£ £ £ £ £
Mr Ahmed Ahmed 36,322 261,978 (150,136 ) - 148,164
The above loan is unsecured, charges interest at the official rate and is repayable on demand.
10. Related Party Transactions
Vivo Property Investments LtdThe director has a significant interest in Vivo Property Investments LtdThe company has provided investment loans to Vivo Property Investments Ltd. The amounted invested included in these accounts as Fixed Asset Investments amounted to £212,609 (2024: £109,722).

Vivo Property Investments Ltd

The director has a significant interest in Vivo Property Investments Ltd

The company has provided investment loans to Vivo Property Investments Ltd. The amounted invested included in these accounts as Fixed Asset Investments amounted to £212,609 (2024: £109,722).

DirectorThe director has a loan balance with the company which is lent on an unsecured, charges interest at the official interest rate with no fixed date for repayment. The balance owed by the director at 31 August 2025 amounted to £148,164 (2024: £36,322)

Director

The director has a loan balance with the company which is lent on an unsecured, charges interest at the official interest rate with no fixed date for repayment. The balance owed by the director at 31 August 2025 amounted to £148,164 (2024: £36,322)

Page 5